FDA
-
-
-
-
-
-
-
CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
-
-
-
-
-
-
-
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
-
-
-
-
-
-
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
-
-
-
-
-
-
-
Cytosorbents (CTSO) Provides Regulatory Update for DrugSorb-ATR
-
-
-
-
-
-
-
Cytosorbents (CTSO) Extends Expiration Date of Outstanding Series B Right Warrants
-
335,228 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


